Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

B of A Securities Upgrades Marathon Oil to Neutral

B of A Securities analyst Doug Leggate upgrades Marathon Oil (NYSE:MRO) from Underperform to Neutral.

byBenzinga Newsdesk

June 21, 2021

1 minute read

B of A Securities analyst Doug Leggate upgrades Marathon Oil (NYSE:MRO) from Underperform to Neutral.

Exelixis’ Phase 3 CONTACT-03 Study Did Not Meet Its Primary Endpoint Of Progression-Free Survival; Shares Fall

By Benzinga Newsdesk

March 3, 5:45 AM

CONTACT-03 evaluated cabozantinib plus atezolizumab versus cabozantinib for locally advanced or metastatic clear cell or non-clear cell (papillary or unclassified only) renal cell carcinoma (RCC) who progressed during

EXEL

B of A Securities Upgrades WEX to Buy

By Benzinga Newsdesk

October 13, 7:29 AM

B of A Securities analyst Mihir Bhatia upgrades WEX (NYSE:WEX) from Neutral to Buy.

WEX

Citigroup Maintains Neutral on NXP Semiconductors, Lowers Price Target to $150

By Benzinga Newsdesk

October 11, 7:43 AM

Citigroup analyst Christopher Danely maintains NXP Semiconductors (NASDAQ:NXPI) with a Neutral and lowers the price target from $190 to $150.

NXPI

KB Home Shares Gain On Better Than Expected Q2 Results

By Akanksha Bakshi

June 22, 4:54 PM

KB Home (NYSE: KBH) reported second-quarter revenue growth of 19% year-o

KBH

B of A Securities Upgrades Marathon Oil to Neutral

Related Posts

Exelixis’ Phase 3 CONTACT-03 Study Did Not Meet Its Primary Endpoint Of Progression-Free Survival; Shares Fall

B of A Securities Upgrades WEX to Buy

Citigroup Maintains Neutral on NXP Semiconductors, Lowers Price Target to $150

KB Home Shares Gain On Better Than Expected Q2 Results